Genetic testing: an economic and contractarian analysis.

[1]  D. Nelkin.  The double-edged helix. , 1994, The New York times on the Web.

[2]  V. Morell.  Evidence found for a possible 'aggression gene'. , 1993, Science.

[3]  N. Kass.  Insurance for the insurers. The use of genetic tests. , 1992, The Hastings Center report.

[4]  T. Murray,et al.  Genetics and the moral mission of health insurance. , 1992, The Hastings Center report.

[5]  D. O. Hall,et al.  Cooling the greenhouse with bioenergy , 1991, Nature.

[6]  J. Maddox.  The case for the human genome , 1991, Nature.

[7]  B. Webb.  UK physicians demand action , 1989, Nature.

[8]  Willard G. Manning,et al.  Adjusting capitation rates using objective health measures and prior utilization , 1989, Health care financing review.

[9]  C. R. Paton.  Medical testing and health insurance. , 1989, British medical journal.

[10]  A. Motulsky,et al.  Impact of genetic manipulation on society and medicine. , 1983, Science.

[11]  J. Riley,et al.  The Analytics of Uncertainty and Information- An Expository Survey , 1979 .

[12]  P. Cook,et al.  The Demand for Insurance and Protection: The Case of Irreplaceable Commodities , 1977 .

[13]  George A. Akerlof,et al.  The Market for “Lemons”: Quality Uncertainty and the Market Mechanism , 1970 .

[14]  H. Ostrer,et al.  Insurance and genetic testing: where are we now? , 1993, American journal of human genetics.

[15]  Gary L. Olin,et al.  Americans' health insurance coverage, 1980-91 , 1992, Health care financing review.

[16]  Z. Harsanyi.  Genetic Prophecy: Beyond the Double Helix , 1981 .

[17]  Peter Tishler.  The Telltale Gene , 1980 .

[18]  J. Hirshleifer.  The Private and Social Value of Information and the Reward to Inventive Activity , 1971 .

[19]  W. Sharpe.  Portfolio Theory and Capital Markets , 1970 .